Kevin Byrne
No Rating Available
(Learn About Our Rating System)

Kevin Byrne, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

1950 Circle of Hope
Salt Lake City , UT 84112
Get Directions

  • Kevin Byrne, MD, Assistant Professor (Clinical), earned his medical degree at Boston University School of Medicine. He completed Adult Psychiatry residency at the University of Utah Spencer Fox Eccles School of Medicine where he served as Chief Resident. He is board certified in Psychiatry by the ABPN. Dr. Byrne's clinical interests include psychiatric care for people with cancer, existential distress, psychedelic treatments for mental health, treatment-resistant mood disorders, trauma and its related conditions, and advanced psychopharmacology. His research focuses on examining psychedelic treatments such as ketamine, MDMA, and psilocybin for the treatment of existential distress and other mental health conditions. Dr. Byrne is excited to be continuing his work as a member of the outpatient teams at the University of Utah Huntsman Mental Health Institute and at the Huntsman Cancer Hospital.

    Specialties

    Board Certification

    American Board of Psychiatry & Neurology (Psychiatry)

  • Kevin Byrne, MD, Assistant Professor (Clinical), earned his medical degree at Boston University School of Medicine. He completed Adult Psychiatry residency at the University of Utah Spencer Fox Eccles School of Medicine where he served as Chief Resident. He is board certified in Psychiatry by the ABPN. Dr. Byrne's clinical interests include psychiatric care for people with cancer, existential distress, psychedelic treatments for mental health, treatment-resistant mood disorders, trauma and its related conditions, and advanced psychopharmacology. His research focuses on examining psychedelic treatments such as ketamine, MDMA, and psilocybin for the treatment of existential distress and other mental health conditions. Dr. Byrne is excited to be continuing his work as a member of the outpatient teams at the University of Utah Huntsman Mental Health Institute and at the Huntsman Cancer Hospital.

    Board Certification and Academic Information

    Academic Departments Psychiatry -Assistant Professor (Clinical)
    Academic Divisions Adult Psychiatry
    Board Certification
    American Board of Psychiatry & Neurology (Psychiatry)

    Education history

    Undergraduate Computer Science - Pomona College B.A.
    Professional Medical Medicine - Boston University School of Medicine M.D.
    Residency Adult Psychiatry - University of Utah Spencer Fox Eccles School of Medicine Resident
    Residency Adult Psychiatry - University of Utah Spencer Fox Eccles School of Medicine Chief Resident

    Selected Publications

    Journal Article

    1. Turner DC, Edmiston AM, Zohner YE, Byrne KJ, Seigfreid WP, Girkin CA, Morris JS, Downs J (2019). Transient Intraocular Pressure Fluctuations: Source, Magnitude, Frequency, and Associated Mechanical Energy. Investigative ophthalmology & visual science, 60(7), 2572-2582. (Read full publication)
    2. Keefe KR, Byrne KJ, Levi J (2018). Treating pediatric post-tonsillectomy pain and nausea with complementary and alternative medicine. The Laryngoscope, 128(11), 2625-2634. (Read full publication)
    3. Fowler ML, Zhu C, Byrne K, Lieber SB, Moore A, Shmerling RH, Paz (2017). Pathogen or contaminant? Distinguishing true infection from synovial fluid culture contamination in patients with suspected septic arthritis. Infection, 45(6), 825-830. (Read full publication)
    4. Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking (2023). HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer. Journal of pain and symptom management, 66(3), 258-269. (Read full publication)
    5. Byrne KJ, Lindsay S, Baker N, Schmutz C, Lewis (2023). In naturalistic psychedelic use, group use is common and acceptable. Journal of psychedelic studies, (Read full publication)
    6. Lewis BR, Byrne K, Hendrick J, Garland EL, Thielking P, Beck (2023). Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial. Journal of psychedelic studies, (Read full publication)
    7. Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland E (2025). Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial. PLoS medicine, 22(9), e1004519. (Read full publication)

    Review

    1. Lewis BR, Byrne (2023). A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder. Focus (American Psychiatric Publishing), 21(3), 247-256. (Read full publication)
    2. Lewis BR, Byrne (2021). Is MDD the right target for early-stage psychedelic-assisted therapy trials?. Journal of psychedelic studies, 5(2), 65-68. (Read full publication)

  • News & Podcasts

    News

Schedule Online